By Reuters Staff
1 Min Read
BRASILIA (Reuters) - The Pan American Health Organization (PAHO) expects the deployment of COVID-19 vaccine made available for poorer countries through the U.N.-led COVAX facility to start in March, with some 164 million doses.
PAHO assistant director Jarbas Barbosa said on Wednesday that the COVAX facility is expected to deploy 2 billion doses of vaccines made by producers that are pre-qualified with the World Health Organization. So far that is only Pfizer Inc of the United States, he said.
Reporting by Anthony Boadle
Polina Ivanova, Rinat Sagdiev, Anton Zverev
4 分钟阅读 Many participants had already quit to seek vaccination Current volunteers will not be “unblinded” Other vaccine makers facing same ethical challenge
By Polina Ivanova, Rinat Sagdiev and Anton Zverev
MOSCOW, Dec 22 (Reuters) - Russia stopped taking in new volunteers in the trial of its first vaccine against COVID-19 on Wednesday, with developers saying it was unethical to administer a placebo to participants now that the shot was increasingly available to the public.
Russia began rolling out the Sputnik V vaccine as part of a national inoculation programme in early December as the final, phase III trial continued in the capital at the same time.
Russia halts new volunteers in Sputnik vaccine trial now it is increasingly available By Polina Ivanova, Rinat Sagdiev and Anton Zverev
A medical worker fills a syringe with Sputnik V (Gam-COVID-Vac) vaccine as she prepares to vaccinate a Russian Army service member at a clinic in the city of Rostov-On-Don
MOSCOW (Reuters) – Russia stopped taking in new volunteers in the trial of its first vaccine against COVID-19 on Wednesday, with developers saying it was unethical to administer a placebo to participants now that the shot was increasingly available to the public.
Russia began rolling out the Sputnik V vaccine as part of a national inoculation programme in early December as the final, phase III trial continued in the capital at the same time.